Chris Degnan
Chief Financial Officer
CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | UroGen Pharma Ltd. (URGN) | Chief Financial Officer | $115,530 | $1,053,789 |
| 2023 | UroGen Pharma Ltd. (URGN) | Chief Financial Officer | — | — |
Earnings-call appearances
-
UroGen Pharma Ltd. Q2 FY2026 Earnings Call2026-08-05
UroGen Pharma Ltd. (URGN)
-
UroGen Pharma Ltd. Q1 FY2026 Earnings Call2026-05-06
UroGen Pharma Ltd. (URGN)
-
UroGen Pharma Ltd. Q2 FY2025 Earnings Call2025-08-07
UroGen Pharma Ltd. (URGN)
-
UroGen Pharma Ltd. Q1 FY2025 Earnings Call2025-05-12
UroGen Pharma Ltd. (URGN)
-
UroGen Pharma Ltd. Q4 FY2024 Earnings Call2025-03-10
UroGen Pharma Ltd. (URGN)
-
UroGen Pharma Ltd. Q3 FY2024 Earnings Call2024-11-06
UroGen Pharma Ltd. (URGN)